ANL 30.68 Increased By ▲ 1.83 (6.34%)
ASC 14.94 Decreased By ▼ -0.21 (-1.39%)
ASL 23.90 Decreased By ▼ -0.25 (-1.04%)
AVN 92.00 Decreased By ▼ -5.95 (-6.07%)
BOP 9.14 Decreased By ▼ -0.16 (-1.72%)
BYCO 10.25 Decreased By ▼ -0.10 (-0.97%)
DGKC 135.60 Increased By ▲ 0.10 (0.07%)
EPCL 50.00 Increased By ▲ 0.02 (0.04%)
FCCL 24.62 Decreased By ▼ -0.54 (-2.15%)
FFBL 24.25 Decreased By ▼ -0.97 (-3.85%)
FFL 15.60 Decreased By ▼ -0.44 (-2.74%)
HASCOL 10.74 Decreased By ▼ -0.33 (-2.98%)
HUBC 85.20 Increased By ▲ 0.20 (0.24%)
HUMNL 7.35 Decreased By ▼ -0.35 (-4.55%)
JSCL 24.85 Decreased By ▼ -0.90 (-3.5%)
KAPCO 37.85 Increased By ▲ 0.40 (1.07%)
KEL 4.15 Decreased By ▼ -0.02 (-0.48%)
LOTCHEM 14.78 Decreased By ▼ -0.35 (-2.31%)
MLCF 46.60 Decreased By ▼ -0.58 (-1.23%)
PAEL 38.25 Decreased By ▼ -1.15 (-2.92%)
PIBTL 11.80 Decreased By ▼ -0.24 (-1.99%)
POWER 10.50 Decreased By ▼ -0.15 (-1.41%)
PPL 90.55 Decreased By ▼ -0.45 (-0.49%)
PRL 26.10 Decreased By ▼ -0.59 (-2.21%)
PTC 8.95 Decreased By ▼ -0.10 (-1.1%)
SILK 1.40 Decreased By ▼ -0.05 (-3.45%)
SNGP 38.10 Decreased By ▼ -0.65 (-1.68%)
TRG 141.10 Decreased By ▼ -4.60 (-3.16%)
UNITY 31.50 Decreased By ▼ -1.40 (-4.26%)
WTL 1.57 Decreased By ▼ -0.04 (-2.48%)
BR100 4,936 Decreased By ▼ -22.94 (-0.46%)
BR30 25,403 Decreased By ▼ -330.65 (-1.28%)
KSE100 45,865 Decreased By ▼ -100.6 (-0.22%)
KSE30 19,173 Decreased By ▼ -26.07 (-0.14%)
World

EU rejects AstraZeneca vaccine contract claims

  • "One of the plants with the highest yield is in the UK because it started earlier," he said.
27 Jan 2021

BRUSSELS: A senior EU official on Wednesday contested drug company AstraZeneca's explanation for a delay in vaccine deliveries and stressed Brussels is demanding it fulfil its contract.

The British-Swedish firm has a deal with the European Commission to supply 400 million doses of its coronavirus vaccine, which is a expected to get EU approval on Friday.

But, due to what it said was a production shortfall in the firm's European plants, the firm has warned that it will miss its target, while still meeting a separate contract it signed with the UK.

In an interview on Tuesday, CEO Pascale Soriot said the UK had signed its contract three months earlier than the EU and this had given the firm time to iron out "glitches" in British plants.

"As for Europe, we are three months behind in fixing those glitches. Would I like to do better? Of course," he said.

"One of the plants with the highest yield is in the UK because it started earlier," he said.

"Anyway, we didn't commit with the EU, by the way. It's not a commitment we have to Europe, it's a 'best effort': we said we are going to make our best effort."

But the European official contested that, and warned that Brussels would hold AstraZeneca to its contract.

"We contest many of the things in the interview, including the idea that the factories in the UK are reserved for UK deliveries. It's not true," the EU official said

"On the idea of 'best effort', in the contract we have redundancies. So if there is a problem in a plant in Belgium we have capacity in other plants in Europe and the UK."

The European Commission has not revealed the text of its contract with the firm, citing commercial confidentiality imposed by AstraZeneca, but it is expected to give a detailed response later Wednesday.